Skip to main content

Table 1 Baseline clinical characteristics of 23 patients with IgG4-related kidney disease

From: Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study

Characteristic

Value (n = 23 patients)

Age, years

62.0 ± 12.0

Gender, male (%)

73.9

Follow-up period (months)

54.9 ± 22.8

Allergy (%)

65.2

Number of extra-renal organs

3.0 ± 1.3

IgG4 (mg/dL)

1069 ± 533

IgG (mg/dL)

3021 ± 1243

IgE (IU/mL)

429 ± 296

Hypocomplementemia (%)

34.8

CRP (mg/dL)

0.25 ± 0.35

Cr (mg/dL)

1.00 ± 0.48

eGFR (mL/min/1.73 m2)

81.7 ± 25.8

Initial dose of PSL (mg/kg/day)

0.57 ± 0.17

Other immunosuppressants (%)

21.7

ARB (%)

21.7

ACEI (%)

0

Relapse (%)

34.8

Diabetes mellitus (%)

30.4

Hypertension (%)

21.7

Ischemic heart disease (%)

4.3

Cerebral vascular disease (%)

0

Smoking habit (%)

52.4

  1. Conversion factor for serum creatinine at diagnosis (Cr) mg/dL to μmol/L, ×88.4. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, CRP serum C-reactive protein at diagnosis, eGFR estimated glomerular filtration rate at diagnosis, IgG serum immunoglobulin G at diagnosis, IgG4 serum immunoglobulin G4 at diagnosis, IgE serum immunoglobulin E at diagnosis, PSL prednisolone